Your medical aesthetics practice is worth more than you think! MSOs and PEGs value practices based on a multiple of free operating cash flow (aka EBITDA). In general, multiples climb as EBITDA grows. TUSK offers a complimentary medical aesthetic practice valuation to owners seeking to understand the true value of their practice.

Examples:

• $1M EBITDA sells for 7x multiple = $7M Total Enterprise Value
• $5M EBITDA practice sells for 10x multiple = $50m Total Enterprise Value

Transactions are complex and time-consuming. Having a representative and advocate will save you time, maximize your deal value, and get you the best structure possible.

TUSK’s seasoned analytics team rebuilds your financials from the general ledger up, identifying every penny that can be added back to maximize your EBITDA. Without an analytics team fighting for your EBITDA, buyers can layer on additional costs or exclude meaningful add-backs form their buyside analysis. TUSK works with medical aesthetic practice owners nationwide to ensure they sell their practice at the highest price with the best-fit partner, all while they continue their day-to-day operations.

A detailed practice valuation helps you understand your practice’s true value, identify areas for improvement, and set realistic expectations for the sale. It’s a critical step in achieving the best possible outcome.

A competitive marketed process typically takes 6-9 months from signing of TUSK’s engagement agreement to close of the transaction. 

It is important to align not only on the valuation they’re giving you for your business, but also on the team, their track record, their timeline, their strategy, and their culture. Most of our sellers stay on for 3-5 years post close and roll 20-40% of their equity into the future partnership, so it is important to be aligned with the MSO or PEG that buys your practice.